Seattle’s Rodeo Therapeutics raises $4.3M more for regenerative therapies, joining prior $3.7M infusion

Rodeo Therapeutics, a Seattle regenerative medicine startup co-founded by Drs. Sanford Markowitz, Stanton Gerson, and Joseph Ready, has added $4.3 million to an earlier $3.7 million cash infusion, building on a $5.9 million Series A from 2017. The company is developing therapies for inflammatory bowel disease and treatments to accelerate cell growth after stem cell transplants, with investors including AbbVie, Lilly, Arch Venture Partners and Johnson & Johnson.

No comments yet.